Sugi Predict

Sugi Predict / Compounds / SCHEMBL6879659

SCHEMBL6879659

SCHEMBL6879659

C=C(C(=O)O)c1csc(-c2ccc(OC)c(C(C)(C)C)c2)c1CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARA P10276 2/20 0.43
▸ RARB P10826 2/20 0.43
▸ RARG P13631 2/20 0.43
▸ ALDH1A1 P00352 6/20 0.33
▸ KDM4E B2RXH2 6/20 0.33
▸ GAA P10253 4/20 0.33
▸ WDR5 P61964 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ PTGDR2 Q9Y5Y4 1/20 0.32
▸ PI4KB Q9UBF8 2/20 0.32
▸ PRKCZ Q05513 2/20 0.31
▸ MAPK1 P28482 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ LMNA P02545 2/20 0.30
▸ HDAC3 O15379 1/20 0.30
▸ HDAC4 P56524 1/20 0.30
▸ HDAC1 Q13547 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6877457 0.77 RARB (0.53) RARARARBRARGALDH1A1KDM4E
SCHEMBL6878042 0.75 RARA (0.51) RARARARBRARGALDH1A1KDM4E
SCHEMBL6876549 0.72 RARA (0.50) RARARARBRARGALDH1A1KDM4E
SCHEMBL7024749 0.69 RARB (0.62) RARARARBRARGALDH1A1WDR5
SCHEMBL6879657 0.69 RARA (0.44) RARARARBRARGALDH1A1KDM4E
SCHEMBL10352726 0.65 RARA (0.61) RARARARBRARGALDH1A1KDM4E
SCHEMBL6871319 0.65 RARA (0.47) RARARARBRARGGAAHPGD
SCHEMBL7024481 0.64 RARA (0.58) RARARARBRARGALDH1A1KDM4E
SCHEMBL6877452 0.64 RARA (0.51) RARARARBRARGALDH1A1KDM4E
SCHEMBL6877448 0.64 RARA (0.51) RARARARBRARGALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825360-B1 Bicyclic aromatic compounds GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) 2004-11-30 — — US disclosed
US-20030135053-A1 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics BERNARDON JEAN-MICHEL 2003-07-17 — — US disclosed
US-20030060491-A1 Bicyclic aromatic compounds BERNARDON JEAN-MICHEL (FR) 2003-03-27 — — US disclosed
US-6515021-B1 Bicyclic aromatic compounds CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2003-02-04 — — US disclosed
US-6147255-A TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL COMPLAINTS ASSOCIATED WITH KERATINIZATION DISORDER WHICH HAS EFFECT ON DIFFERENTIATION AND ON PROLIFERATION CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2000-11-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060491-A1 Bicyclic aromatic compounds MITF, TYR, PAH RARA 451/4885RARB 529/4885RARG 474/4885
US-20030135053-A1 For use in human or veterinary conditions, that may be dermatological, rheumatic, respiratory, or cardiovascular and may be used in cosmetics MITF, TYR, PAH RARA 52/4885RARB 93/4885RARG 69/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.